Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|10|2|133-140

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.10, Iss.2, 2011-01, pp. : 133-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydrogen Sulfide-Based Anti-Inflammatory and Chemopreventive Therapies: An Experimental Approach

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 3012-3022

Bentham Science Publishers

Access to resources Recommend Favorite

COXIBs, CINODs and H2S-Releasing NSAIDs: Current Perspectives in the Development of Safer Non Steroidal Anti-Inflammatory Drugs

By  

Current Medicinal Chemistry, Vol. 18, Iss. 23, 2011-08 ,pp. : 3494-3505

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2s preferred over nonselective NSAIDs in coumarin recipients

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Nitric Oxide-Releasing NSAIDs: A Review of Their Current Status

By Fiorucci S.  

Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Old and New Gasotransmitters in the Cardiovascular System: Focus on the Role of Nitric Oxide and Hydrogen Sulfide in Endothelial Cells and Cardiomyocytes

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 9, 2011-09 ,pp. : 1406-1415

Bentham Science Publishers

Access to resources Recommend Favorite